Live tape
Top 8, mentions 7d6,922META1,781 mentions▲ +0.06GOOGL1,419 mentions▲ +0.03NVDA881 mentions▲ +0.09TSLA654 mentions▲ +0.06MSFT574 mentions▲ +0.06SPY567 mentions▲ +0.03AMZN550 mentions▲ +0.04AAPL496 mentions▲ +0.07

Equity · Real Estate

CWK

NYSE

Cushman & Wakefield Limited

$13.13 +3.10% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 27, 2026
Price · Chart
Our own end-of-day closes 17 sessions
$15 $12 2 Jul 27 Jul

The line runs $13.99 on 2 July through $13.13 on 27 July, on a scale from $12 to $15. Days the market did not trade hold the previous close, flat.

The chart above plots the price of CWK over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 17 sessions over that window: $13.99 on 2 July 2026 through $13.13 on 27 July 2026.

Market cap $3.1B
P/E (TTM) 45.3
52-week range $11.41 – $17.06
Avg volume 448.9K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 27, 2026

CWK insider trades

SEC Form 4 · last 90 days · newest reported trade 8 Sep 2026
Open-market buys 0
Open-market sells 2
Net sold $389K
Non-trade filings 2
Date Insider Type Shares Value
08 Sep 2026 Robinson Nathaniel See Remarks Sell 12,500 $167K
13 Aug 2026 Sayed Laurida See Remarks Sell 16,000 $222K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
01 Aug 2026 Daimler Susan Director Option exercise 11,873 $159K
01 Aug 2026 Wennes Timothy H Director Option exercise 11,873 $159K

CWK reported financials

SEC EDGAR XBRL

CWK reported revenue of $10.3B for the fiscal year ended 31 Dec 2025. Net income over the same period was $88.2M.

Figure Reported Period
Revenue $10.3B 31 Dec 2025 fiscal year
Net income $88.2M 31 Dec 2025 fiscal year
Diluted EPS $0.38 31 Dec 2025 fiscal year
Total assets $7.6B 30 Jun 2026 at period end
Total equity $2.0B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

CWK earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.22 $2.76B
31 Mar 2026 Q1 2026 $-0.05 $2.54B
31 Dec 2025 FY 2025 $0.38 $10.29B
30 Sep 2025 Q3 2025 $0.22 $2.61B
30 Jun 2025 Q2 2025 $0.25 $2.48B
31 Mar 2025 Q1 2025 $0.01 $2.28B
31 Dec 2024 FY 2024 $0.56 $9.45B
30 Sep 2024 Q3 2024 $0.14 $2.34B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CWK institutional holders

SEC Form 13F

5 of the 45 institutional funds we track reported a CWK position for the quarter ended 30 Jun 2026 — a combined $40.0M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
D. E. Shaw & Co. Trimmed −29.5% shares 1,117,856 $15.0M
Renaissance Technologies Added +58.4% shares 788,000 $10.6M
AQR Capital Management Held (±25%) −7.1% shares 544,313 $7.3M
Balyasny Asset Management Trimmed −74.5% shares 313,011 $4.2M
Marshall Wace New position 225,527 $3.0M
Man Group Exited

Source: SEC EDGAR 13F filings

CWK fails-to-deliver

SEC CNS data

On 09 Sep 2026, 121 shares of CWK failed to deliver (about $2K).

Settlement date Shares failed Notional % of shares out
09 Sep 2026 121 $2K <0.001%
25 Aug 2026 1,695 $25K 0.001%
21 Aug 2026 1,162 $17K <0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in CWK

STOCK Act disclosures

The most recent congressional trade disclosed in CWK is a sale by Daniel S. Goldman (house, NY), dated 10 Apr 2023.

Date Member Type Amount
10 Apr 2023 filed 19 May 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K
30 Nov 2022 filed 29 Dec 2022 Susie Lee house · Democrat–NV Sale $1K–$15K
21 Jun 2021 filed 13 Jul 2021 Susie Lee house · Democrat–NV Purchase $1K–$15K
17 Jun 2021 filed 13 Jul 2021 Susie Lee house · Democrat–NV Purchase $1K–$15K

Source: U.S. House of Representatives financial disclosures